Imran is the founding partner at Action Potential Venture Capital in Cambridge, MA. He represents APVC on the Boards of Alpheus Medical, Axon Therapies, Neuspera Medical and SetPoint Medical.
Before joining Action Potential, Imran was in the Worldwide Business Development group of GlaxoSmithKline working in a variety of business development and investing roles. Imran led the establishment of and headed up the Investment Management practice at GSK. The group was tasked with accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds as limited partners and direct investments in biotechs made as part of GSK’s R&D collaborations.
Imran received his bachelor’s degree in finance from Concordia University in his native Canada and has trained as a Chartered Accountant.